ArriVent BioPharma Statistics
Total Valuation
AVBP has a market cap or net worth of $793.36 million. The enterprise value is $420.59 million.
| Market Cap | 793.36M |
| Enterprise Value | 420.59M |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVBP has 49.31 million shares outstanding. The number of shares has increased by 30.39% in one year.
| Current Share Class | 49.31M |
| Shares Outstanding | 49.31M |
| Shares Change (YoY) | +30.39% |
| Shares Change (QoQ) | +5.63% |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 70.20% |
| Float | 32.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 103.87 |
| PB Ratio | 2.17 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.16, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.16 |
| Quick Ratio | 13.40 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.25% and return on invested capital (ROIC) is -35.64%.
| Return on Equity (ROE) | -53.25% |
| Return on Assets (ROA) | -33.11% |
| Return on Invested Capital (ROIC) | -35.64% |
| Return on Capital Employed (ROCE) | -47.96% |
| Weighted Average Cost of Capital (WACC) | 11.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.13M |
| Employee Count | 77 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.87% in the last 52 weeks. The beta is 1.35, so AVBP's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -22.87% |
| 50-Day Moving Average | 28.20 |
| 200-Day Moving Average | 27.18 |
| Relative Strength Index (RSI) | 22.51 |
| Average Volume (20 Days) | 2,054,255 |
Short Selling Information
The latest short interest is 8.45 million, so 17.14% of the outstanding shares have been sold short.
| Short Interest | 8.45M |
| Short Previous Month | 8.77M |
| Short % of Shares Out | 17.14% |
| Short % of Float | 26.20% |
| Short Ratio (days to cover) | 13.52 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -175.94M |
| Pretax Income | -164.21M |
| Net Income | -164.21M |
| EBITDA | n/a |
| EBIT | -175.94M |
| Earnings Per Share (EPS) | -$3.70 |
Balance Sheet
The company has $373.12 million in cash and $351,000 in debt, with a net cash position of $372.77 million or $7.56 per share.
| Cash & Cash Equivalents | 373.12M |
| Total Debt | 351,000 |
| Net Cash | 372.77M |
| Net Cash Per Share | $7.56 |
| Equity (Book Value) | 366.84M |
| Book Value Per Share | 7.59 |
| Working Capital | 366.33M |
Cash Flow
| Operating Cash Flow | -147.93M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -147.93M |
| FCF Per Share | -$3.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -30.39% |
| Shareholder Yield | -30.39% |
| Earnings Yield | -20.72% |
| FCF Yield | -18.67% |
Analyst Forecast
The average price target for AVBP is $20.56, which is 27.78% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.56 |
| Price Target Difference | 27.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |